Guidelines for investigating causality of sequence variants in human disease

By D. MacArthur, T. Manolio, D. Dimmock, H. Rehm, Jay Shendure, Gonçalo R. Abecasis, D. Adams, Russ B. Altman, Stylianos E. Antonarakis, Euan A. Ashley and 17 more. 2014

1,235 citations recorded by the source corpus.

The discovery of rare genetic variants is accelerating, and clear guidelines for distinguishing disease-causing sequence variants from the many potentially functional variants present in any human genome are urgently needed. Without rigorous standards we risk an acceleration of false-positive reports of causality, which would impede the translation of genomic research findings into the clinical diagnostic setting and hinder biological understanding of disease. Here we discuss the key challenges of assessing sequence variants in human disease, integrating both gene-level and variant-level support for causality. We propose guidelines for summarizing confidence in variant pathogenicity and highlight several areas that require further resource development.

Subfields: Cancer Research, Genetics, Causal Inference & Discovery, Computational Biology & Bioinformatics

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

  1. Mark Yandell
  2. Computational Pan-Genomics Consortium
  3. Aaron R. Quinlan

In Genetics

  1. Kai-Uwe Eckardt
  2. Isaac S. Kohane
  3. Mark Yandell
  4. Karen Eilbeck
  5. Karl V. Voelkerding
  6. Jessica Alföldi
  7. Computational Pan-Genomics Consortium
  8. Aaron R. Quinlan

In Computational Biology & Bioinformatics

  1. Mark Yandell
  2. Karen Eilbeck
  3. Jessica Alföldi
  4. UniProt Consortium
  5. Computational Pan-Genomics Consortium
  6. Aaron R. Quinlan
  7. Beryl B. Cummings
  8. J. Kosmicki

Citations in the corpus